Published in Lancet on February 20, 1988
Endocrine-disrupting chemicals: an Endocrine Society scientific statement. Endocr Rev (2009) 9.60
Cancer risks from arsenic in drinking water. Environ Health Perspect (1992) 6.98
Cancer potential in liver, lung, bladder and kidney due to ingested inorganic arsenic in drinking water. Br J Cancer (1992) 3.46
Risk of internal cancers from arsenic in drinking water. Environ Health Perspect (2000) 3.29
The broad scope of health effects from chronic arsenic exposure: update on a worldwide public health problem. Environ Health Perspect (2013) 2.92
Arsenic exposure and toxicology: a historical perspective. Toxicol Sci (2011) 2.63
Probabilistic Modeling of Dietary Arsenic Exposure and Dose and Evaluation with 2003-2004 NHANES Data. Environ Health Perspect (2010) 2.38
Reduction in urinary arsenic levels in response to arsenic mitigation efforts in Araihazar, Bangladesh. Environ Health Perspect (2007) 2.03
Chronic arsenic exposure and risk of infant mortality in two areas of Chile. Environ Health Perspect (2000) 1.85
Arsenic concentrations in well water and risk of bladder and kidney cancer in Finland. Environ Health Perspect (1999) 1.84
Lung cancer in a U.S. population with low to moderate arsenic exposure. Environ Health Perspect (2009) 1.77
Influence of arsenate and arsenite on signal transduction pathways: an update. Arch Toxicol (2010) 1.76
Cancer burden from arsenic in drinking water in Bangladesh. Am J Public Health (2004) 1.68
Arsenic in drinking-water and risk for cancer in Denmark. Environ Health Perspect (2008) 1.58
Effects of arsenic exposure on DNA methylation and epigenetic gene regulation. Epigenomics (2010) 1.56
Liver is a target of arsenic carcinogenesis. Toxicol Sci (2008) 1.55
No association between arsenic exposure from drinking water and diabetes mellitus: a cross-sectional study in Bangladesh. Environ Health Perspect (2010) 1.48
Inorganic arsenic and human prostate cancer. Environ Health Perspect (2008) 1.47
Heavy metals in water of the San Pedro River in Chihuahua, Mexico and its potential health risk. Int J Environ Res Public Health (2008) 1.43
Epigenetic remodeling during arsenical-induced malignant transformation. Carcinogenesis (2008) 1.27
Arsenic in tube well water in Bangladesh: health and economic impacts and implications for arsenic mitigation. Bull World Health Organ (2012) 1.24
Arsenic exposure and cancer mortality in a US-based prospective cohort: the strong heart study. Cancer Epidemiol Biomarkers Prev (2013) 1.23
Utility of recent studies to assess the National Research Council 2001 estimates of cancer risk from ingested arsenic. Environ Health Perspect (2010) 1.21
Arsenic in drinking water and urinary tract cancers: a systematic review of 30 years of epidemiological evidence. Environ Health (2014) 1.19
Prevalence of non-insulin-dependent diabetes mellitus and related vascular diseases in southwestern arseniasis-endemic and nonendemic areas in Taiwan. Environ Health Perspect (2003) 1.17
Association between arsenic exposure from drinking water and plasma levels of soluble cell adhesion molecules. Environ Health Perspect (2007) 1.15
Endocrine disruptors and prostate cancer risk. Endocr Relat Cancer (2008) 1.14
In utero and postnatal exposure to arsenic alters pulmonary structure and function. Toxicol Appl Pharmacol (2008) 1.13
Drinking water and cancer. Environ Health Perspect (1995) 1.09
Epigenetic mediated transcriptional activation of WNT5A participates in arsenical-associated malignant transformation. Toxicol Appl Pharmacol (2008) 1.08
Increased morbidity odds ratio of primary liver cancer and cirrhosis of the liver among vinyl chloride monomer workers. Occup Environ Med (1998) 1.01
Monomethylarsonous acid produces irreversible events resulting in malignant transformation of a human bladder cell line following 12 weeks of low-level exposure. Toxicol Sci (2010) 1.01
Oxidative stress and hepatic stellate cell activation are key events in arsenic induced liver fibrosis in mice. Toxicol Appl Pharmacol (2010) 0.99
A prospective study of blood selenium levels and the risk of arsenic-related premalignant skin lesions. Cancer Epidemiol Biomarkers Prev (2007) 0.98
Arsenic contamination in groundwater in the Southeast Asia region. Environ Geochem Health (2009) 0.98
Association between arsenic exposure from drinking water and proteinuria: results from the Health Effects of Arsenic Longitudinal Study. Int J Epidemiol (2011) 0.97
Low-dose arsenic: in search of a risk threshold. Environ Health Perspect (2014) 0.93
Assessing the measurement precision of various arsenic forms and arsenic exposure in the National Human Exposure Assessment Survey (NHEXAS). Environ Health Perspect (2006) 0.92
Actions of estrogens and endocrine disrupting chemicals on human prostate stem/progenitor cells and prostate cancer risk. Mol Cell Endocrinol (2011) 0.90
Chemoprevention of bladder cancer. World J Urol (2006) 0.90
Interdependent genotoxic mechanisms of monomethylarsonous acid: role of ROS-induced DNA damage and poly(ADP-ribose) polymerase-1 inhibition in the malignant transformation of urothelial cells. Toxicol Appl Pharmacol (2011) 0.89
Health effects of chronic arsenic exposure. J Prev Med Public Health (2014) 0.88
Human biomonitoring of arsenic and antimony in case of an elevated geogenic exposure. Environ Health Perspect (1998) 0.88
An increased standardised mortality ratio for liver cancer among polyvinyl chloride workers in Taiwan. Occup Environ Med (2002) 0.87
Arsenic Exposure and Subclinical Endpoints of Cardiovascular Diseases. Curr Environ Health Rep (2014) 0.87
Age adjustment in ecological studies: using a study on arsenic ingestion and bladder cancer as an example. BMC Public Health (2011) 0.86
Cancer risks associated with arsenic in drinking water. Environ Health Perspect (2007) 0.84
Arsenic in private well water part 1 of 3: Impact of the New Jersey Private Well Testing Act on household testing and mitigation behavior. Sci Total Environ (2016) 0.84
Arsenic exposure induces the Warburg effect in cultured human cells. Toxicol Appl Pharmacol (2013) 0.84
Interactive Effects of N6AMT1 and As3MT in Arsenic Biomethylation. Toxicol Sci (2015) 0.84
Genome-wide association study identified SNP on 15q24 associated with bladder cancer risk in Japanese population. Hum Mol Genet (2014) 0.83
Geographic patterns of hepatocellular carcinoma mortality with exposure to iron in groundwater in Taiwanese population: an ecological study. BMC Public Health (2013) 0.82
Genetic polymorphisms in glutathione S-transferase (GST) superfamily and risk of arsenic-induced urothelial carcinoma in residents of southwestern Taiwan. J Biomed Sci (2011) 0.82
Association between arsenic exposure from drinking water and hematuria: results from the Health Effects of Arsenic Longitudinal Study. Toxicol Appl Pharmacol (2014) 0.81
Arsenite activates NFκB through induction of C-reactive protein. Toxicol Appl Pharmacol (2012) 0.80
Persistence of DNA damage following exposure of human bladder cells to chronic monomethylarsonous acid. Toxicol Appl Pharmacol (2009) 0.80
Early-life or lifetime sun exposure, sun reaction, and the risk of squamous cell carcinoma in an Asian population. Cancer Causes Control (2010) 0.79
Involvement of epigenetics and EMT-related miRNA in arsenic-induced neoplastic transformation and their potential clinical use. Cancer Prev Res (Phila) (2015) 0.79
Induction of human squamous cell-type carcinomas by arsenic. J Skin Cancer (2011) 0.78
Risk Assessment of Arsenic in Rice Cereal and Other Dietary Sources for Infants and Toddlers in the U.S. Int J Environ Res Public Health (2016) 0.78
Methylated trivalent arsenic-glutathione complexes are more stable than their arsenite analog. Bioinorg Chem Appl (2008) 0.77
Glucuronidation and UGT isozymes in bladder: new targets for the treatment of uroepithelial carcinomas? Oncotarget (2016) 0.77
Arsenic removal from water using flame-synthesized iron oxide nanoparticles with variable oxidation states. Aerosol Sci Technol (2013) 0.77
Occupational neurotoxic diseases in taiwan. Saf Health Work (2012) 0.76
Arsenic Exposure and Type 2 Diabetes: MicroRNAs as Mechanistic Links? Curr Diab Rep (2017) 0.75
Interactive Influence of N6AMT1 and As3MT Genetic Variations on Arsenic Metabolism in the Population of Inner Mongolia, China. Toxicol Sci (2016) 0.75
Arsenic in drinking water and prostate cancer in Illinois counties: An ecologic study. Environ Res (2016) 0.75
Spatial Analysis of Human Health Risk Due to Arsenic Exposure through Drinking Groundwater in Taiwan's Pingtung Plain. Int J Environ Res Public Health (2017) 0.75
Low-level arsenic exposure from drinking water is associated with prostate cancer in Iowa. Environ Res (2017) 0.75
Internal duplication and homology with bacterial transport proteins in the mdr1 (P-glycoprotein) gene from multidrug-resistant human cells. Cell (1986) 8.53
Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group. N Engl J Med (1997) 6.03
KIT activation is a ubiquitous feature of gastrointestinal stromal tumors. Cancer Res (2001) 5.40
Dose-response relation between arsenic concentration in well water and mortality from cancers and vascular diseases. Am J Epidemiol (1989) 4.37
PAX8-PPARgamma1 fusion oncogene in human thyroid carcinoma [corrected]. Science (2000) 3.87
Cancer potential in liver, lung, bladder and kidney due to ingested inorganic arsenic in drinking water. Br J Cancer (1992) 3.46
Malignant neoplasms among residents of a blackfoot disease-endemic area in Taiwan: high-arsenic artesian well water and cancers. Cancer Res (1985) 3.44
Risk of internal cancers from arsenic in drinking water. Environ Health Perspect (2000) 3.29
The human multidrug resistance (mdr1) gene. cDNA cloning and transcription initiation. J Biol Chem (1987) 3.13
Prevalence of myopia in Taiwanese schoolchildren: 1983 to 2000. Ann Acad Med Singapore (2004) 3.01
KIT extracellular and kinase domain mutations in gastrointestinal stromal tumors. Am J Pathol (2000) 2.99
Epidemiologic study of ocular refraction among schoolchildren in Taiwan in 1995. Optom Vis Sci (1999) 2.93
Incidence of transitional cell carcinoma and arsenic in drinking water: a follow-up study of 8,102 residents in an arseniasis-endemic area in northeastern Taiwan. Am J Epidemiol (2001) 2.82
Incidence of internal cancers and ingested inorganic arsenic: a seven-year follow-up study in Taiwan. Cancer Res (1995) 2.75
Environmental risk factors and Parkinson's disease: a case-control study in Taiwan. Neurology (1997) 2.61
Evidence for linkage of a candidate chromosome 1 region to human systemic lupus erythematosus. J Clin Invest (1997) 2.57
A retrospective study on malignant neoplasms of bladder, lung and liver in blackfoot disease endemic area in Taiwan. Br J Cancer (1986) 2.37
Prognostic values of tumor necrosis factor/cachectin, interleukin-1, interferon-alpha, and interferon-gamma in the serum of patients with septic shock. Swiss-Dutch J5 Immunoglobulin Study Group. J Infect Dis (1990) 2.36
Increased prevalence of hypertension and long-term arsenic exposure. Hypertension (1995) 2.36
Fluconazole prophylaxis prevents intra-abdominal candidiasis in high-risk surgical patients. Crit Care Med (1999) 2.35
Hepatitis C virus infection in an area hyperendemic for hepatitis B and chronic liver disease: the Taiwan experience. J Infect Dis (1990) 2.30
Serologic markers of Epstein-Barr virus infection and nasopharyngeal carcinoma in Taiwanese men. N Engl J Med (2001) 2.26
Lower BMI cut-off value to define obesity in Hong Kong Chinese: an analysis based on body fat assessment by bioelectrical impedance. Br J Nutr (2001) 2.25
Familial risk of hepatocellular carcinoma among chronic hepatitis B carriers and their relatives. J Natl Cancer Inst (2000) 2.23
Atherogenicity and carcinogenicity of high-arsenic artesian well water. Multiple risk factors and related malignant neoplasms of blackfoot disease. Arteriosclerosis (1988) 2.20
Ingested inorganic arsenic and prevalence of diabetes mellitus. Am J Epidemiol (1994) 2.17
Hormonal markers and hepatitis B virus-related hepatocellular carcinoma risk: a nested case-control study among men. J Natl Cancer Inst (2001) 2.11
Arsenic methylation capacity and skin cancer. Cancer Epidemiol Biomarkers Prev (2000) 2.07
An altered pattern of cross-resistance in multidrug-resistant human cells results from spontaneous mutations in the mdr1 (P-glycoprotein) gene. Cell (1988) 2.01
Long-term arsenic exposure and incidence of non-insulin-dependent diabetes mellitus: a cohort study in arseniasis-hyperendemic villages in Taiwan. Environ Health Perspect (2000) 1.98
Serum beta-carotene level, arsenic methylation capability, and incidence of skin cancer. Cancer Epidemiol Biomarkers Prev (1997) 1.84
Prospective study of hepatocellular carcinoma and liver cirrhosis in asymptomatic chronic hepatitis B virus carriers. Am J Epidemiol (1997) 1.83
Dose-response relationship between prevalence of cerebrovascular disease and ingested inorganic arsenic. Stroke (1997) 1.81
Sudden infant death syndrome in relation to weather and optimetrically measured air pollution in Taiwan. Pediatrics (1995) 1.79
Epidemiologic study of the prevalence and severity of myopia among schoolchildren in Taiwan in 2000. J Formos Med Assoc (2001) 1.79
Congenital mesoblastic nephroma t(12;15) is associated with ETV6-NTRK3 gene fusion: cytogenetic and molecular relationship to congenital (infantile) fibrosarcoma. Am J Pathol (1998) 1.72
Aflatoxin exposure and risk of hepatocellular carcinoma in Taiwan. Int J Cancer (1996) 1.71
Arsenic methylation capacity, body retention, and null genotypes of glutathione S-transferase M1 and T1 among current arsenic-exposed residents in Taiwan. Mutat Res (1997) 1.69
Hepatitis B virus markers in Chinese twins. Anticancer Res (1989) 1.68
The role of hepatitis B and C viruses in hepatocellular carcinoma in a hepatitis B endemic area. A case-control study. Cancer (1992) 1.68
Human papillomavirus and cervical neoplasia: a case-control study in Taiwan. Int J Cancer (1995) 1.66
Multiple risk factors associated with arsenic-induced skin cancer: effects of chronic liver disease and malnutritional status. Br J Cancer (1995) 1.65
Characterization of the hgbA locus encoding a hemoglobin receptor from Haemophilus ducreyi. Infect Immun (1995) 1.56
Mortality attributable to cigarette smoking in Taiwan: a 12-year follow-up study. Tob Control (1998) 1.47
Elevated levels of anticardiolipin antibodies and epilepsy in lupus patients. Lupus (1996) 1.44
Seasonal pattern of posttraumatic stress disorder admissions. Compr Psychiatry (1996) 1.44
CYP2E1 genetic polymorphisms and risk of nasopharyngeal carcinoma in Taiwan. J Natl Cancer Inst (1997) 1.43
A chemical and genetic approach together define the biological consequences of 3-methyladenine lesions in the mammalian genome. J Biol Chem (1998) 1.42
Impaired pulmonary function as a risk factor for mortality. Am J Epidemiol (1982) 1.38
Amplification and overexpression of cyclin D1 in human hepatocellular carcinoma. Biochem Biophys Res Commun (1993) 1.38
A p53 genetic polymorphism as a modulator of hepatocellular carcinoma risk in relation to chronic liver disease, familial tendency, and cigarette smoking in hepatitis B carriers. Hepatology (1999) 1.38
Induction of apoptosis in murine coronavirus-infected cultured cells and demonstration of E protein as an apoptosis inducer. J Virol (1999) 1.38
Nation-wide survey of myopia among schoolchildren in Taiwan, 1986. Acta Ophthalmol Suppl (1988) 1.38
A case-control study of primary hepatocellular carcinoma in Taiwan. Cancer (1988) 1.35
Low serum carotene level and increased risk of ischemic heart disease related to long-term arsenic exposure. Atherosclerosis (1998) 1.35
Occupational exposure to wood, formaldehyde, and solvents and risk of nasopharyngeal carcinoma. Cancer Epidemiol Biomarkers Prev (2001) 1.34
Hepatitis B vaccination and hepatocellular carcinoma rates in boys and girls. JAMA (2000) 1.33
Crystal structure of the transcription factor sc-mtTFB offers insights into mitochondrial transcription. Protein Sci (2001) 1.33
Aggressive peripheral T-cell lymphomas containing Epstein-Barr viral DNA: a clinicopathologic and molecular analysis. Blood (1991) 1.32
Cigarette smoking, alcohol consumption and risk of nasopharyngeal carcinoma in Taiwan. Cancer Causes Control (1999) 1.32
Urinary levels of inorganic and organic arsenic metabolites among residents in an arseniasis-hyperendemic area in Taiwan. J Toxicol Environ Health A (1998) 1.32
Elevated serum testosterone levels and risk of hepatocellular carcinoma. Cancer Res (1993) 1.31
Structure of the Ca2+-regulated photoprotein obelin at 1.7 A resolution determined directly from its sulfur substructure. Protein Sci (2000) 1.29
DNA repair methyltransferase (Mgmt) knockout mice are sensitive to the lethal effects of chemotherapeutic alkylating agents. Mutagenesis (1999) 1.28
An evaluation of maximum likelihood reconstruction for SPECT. IEEE Trans Med Imaging (1990) 1.28
Excess injury mortality among smokers: a neglected tobacco hazard. Tob Control (2005) 1.25
CD34, CD117, and actin expression in phyllodes tumor of the breast. J Surg Res (2000) 1.24
Dose-response relationship between peripheral vascular disease and ingested inorganic arsenic among residents in blackfoot disease endemic villages in Taiwan. Atherosclerosis (1996) 1.24
Genetic polymorphism of epoxide hydrolase and glutathione S-transferase in COPD. Eur Respir J (2004) 1.23
p53 mutations, chronic hepatitis B virus infection, and aflatoxin exposure in hepatocellular carcinoma in Taiwan. Cancer Res (1997) 1.23
Genetic polymorphisms of CYP2E1, GSTM1, and GSTT1; environmental factors and risk of oral cancer. Cancer Epidemiol Biomarkers Prev (1997) 1.23
Androgen-receptor gene CAG repeats, plasma testosterone levels, and risk of hepatitis B-related hepatocellular carcinoma. J Natl Cancer Inst (2000) 1.22
Persistent hyperendemicity of hepatitis C virus infection in Taiwan: the important role of iatrogenic risk factors. J Med Virol (2001) 1.22
The amino-terminal C/H1 domain of CREB binding protein mediates zta transcriptional activation of latent Epstein-Barr virus. Mol Cell Biol (1999) 1.22
Tobacco, betel quid, alcohol, and illicit drug use among 13- to 35-year-olds in I-Lan, rural Taiwan: prevalence and risk factors. Am J Public Health (2001) 1.22
Inducible and conditional inhibition of human immunodeficiency virus proviral expression by vesicular stomatitis virus matrix protein. J Virol (1995) 1.21
Functional motifs of delta antigen essential for RNA binding and replication of hepatitis delta virus. J Virol (1993) 1.21
PTEN/MMAC1 mutations in hepatocellular carcinomas. Oncogene (1999) 1.20
Genetic polymorphisms of XRCC1 and risk of the esophageal cancer. Int J Cancer (2001) 1.20
Risk of betel chewing for oesophageal cancer in Taiwan. Br J Cancer (2001) 1.20
Transmission of hepatitis C virus in Taiwan: prevalence and risk factors based on a nationwide survey. J Med Virol (1999) 1.18
Association between hepatitis C virus antibodies and hepatocellular carcinoma in Taiwan. Cancer Res (1991) 1.18
Hepatitis B and C viruses in the development of hepatocellular carcinoma. Crit Rev Oncol Hematol (1994) 1.17
Genetic polymorphisms of glutathione S-transferases M1 and T1 associated with susceptibility to aflatoxin-related hepatocarcinogenesis among chronic hepatitis B carriers: a nested case-control study in Taiwan. Carcinogenesis (2001) 1.17
Association of blood arsenic levels with increased reactive oxidants and decreased antioxidant capacity in a human population of northeastern Taiwan. Environ Health Perspect (2001) 1.15
Cytochrome P450 2E1 and glutathione S-transferase M1 polymorphisms and susceptibility to hepatocellular carcinoma. Gastroenterology (1995) 1.15
Comparative rates of elimination of some individual polychlorinated biphenyls from the blood of PCB-poisoned patients in Taiwan. Food Chem Toxicol (1982) 1.14
The nucleolin binding activity of hepatitis delta antigen is associated with nucleolus targeting. J Biol Chem (1998) 1.14
Levels and gas chromatographic patterns of polychlorinated biphenyls in the blood of patients after PCB poisoning in Taiwan. Bull Environ Contam Toxicol (1980) 1.14
Carcinoembryonic antigen cell adhesion molecule 1 directly associates with cytoskeleton proteins actin and tropomyosin. J Biol Chem (2001) 1.13